# WES Pharma Inc. – FDA Inspection, Nov 21, 2023

Source: https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/37ef8a8b-4e2f-433a-b55a-1a0aa0bf154b
Source feed: FDA_Inspections

> FDA inspection 1223324 of WES Pharma Inc., November 21, 2023. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 211. Form 483 issued. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1223324
- Company Name: WES Pharma Inc.
- Inspection Date: 2023-11-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1290200 - 2025-11-20](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/86fcfabf-984e-4912-bcd9-e4ce9321452c)
- FDA Inspection 1162565 - 2022-02-18
- FDA Inspection 1141774 - 2021-04-28
- FDA Inspection 1114327 - 2019-12-20
- [FDA Inspection 1088267 - 2019-04-19](https://www.keypedia.com/records/fda_inspections/wes-pharma-inc/77a565d3-899b-466f-9b49-b46e7e538afb)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/johnny-d-nwankwo/12d510d9-2ea8-44ae-807f-c8c05f63ce68)
- [Investigator](https://www.keypedia.com/people/olumide-a-akinyemi/a520acd2-450c-4624-a7af-b871e4fad9c7)
- [FDA Associated Person](https://www.keypedia.com/people/pushpa-s-jayasekara/cfd7d22f-b4c2-4002-ae18-b5435815d27d)
- [Yaharn Su](https://www.keypedia.com/people/yaharn-su/75b7f7fd-d853-436e-b538-386a8c6df3cb)

Company: https://www.keypedia.com/companies/wes-pharma-inc/26195242-bcfc-4382-817b-4d9d153b962d

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
